These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
328 related articles for article (PubMed ID: 37386521)
1. Identification of STEAP3-based molecular subtype and risk model in ovarian cancer. Zhao Z; Sun C; Hou J; Yu P; Wei Y; Bai R; Yang P J Ovarian Res; 2023 Jun; 16(1):126. PubMed ID: 37386521 [TBL] [Abstract][Full Text] [Related]
2. Acetylation model predicts prognosis of patients and affects immune microenvironment infiltration in epithelial ovarian carcinoma. Wang X; Li X; Wei L; Yu Y; Hazaisihan Y; Tao L; Jia W J Ovarian Res; 2024 Jul; 17(1):150. PubMed ID: 39030559 [TBL] [Abstract][Full Text] [Related]
3. A signature based on glycosyltransferase genes provides a promising tool for the prediction of prognosis and immunotherapy responsiveness in ovarian cancer. Xu X; Wu Y; Jia G; Zhu Q; Li D; Xie K J Ovarian Res; 2023 Jan; 16(1):5. PubMed ID: 36611197 [TBL] [Abstract][Full Text] [Related]
4. Molecular Characterization of Cuproptosis-related lncRNAs: Defining Molecular Subtypes and a Prognostic Signature of Ovarian Cancer. Li N; Yu K; Huang D; Li S; Zeng D; Li J; Fan L Biol Trace Elem Res; 2024 Apr; 202(4):1428-1445. PubMed ID: 37528285 [TBL] [Abstract][Full Text] [Related]
5. Identification of copper metabolism-related subtypes and establishment of the prognostic model in ovarian cancer. Zhao S; Zhang X; Gao F; Chi H; Zhang J; Xia Z; Cheng C; Liu J Front Endocrinol (Lausanne); 2023; 14():1145797. PubMed ID: 36950684 [TBL] [Abstract][Full Text] [Related]
6. A novel tumor mutational burden-based risk model predicts prognosis and correlates with immune infiltration in ovarian cancer. Wang H; Liu J; Yang J; Wang Z; Zhang Z; Peng J; Wang Y; Hong L Front Immunol; 2022; 13():943389. PubMed ID: 36003381 [TBL] [Abstract][Full Text] [Related]
7. Upregulation of the ferroptosis-related Yuan L; Liu J; Bao L; Qu H; Xiang J; Sun P Front Oncol; 2023; 13():1032364. PubMed ID: 37064114 [TBL] [Abstract][Full Text] [Related]
8. A signature based on anoikis-related genes for the evaluation of prognosis, immunoinfiltration, mutation, and therapeutic response in ovarian cancer. Duan Y; Xu X Front Endocrinol (Lausanne); 2023; 14():1193622. PubMed ID: 37383389 [TBL] [Abstract][Full Text] [Related]
9. Identification of cuproptosis-related subtypes, construction of a prognosis model, and tumor microenvironment landscape in gastric cancer. Wang J; Qin D; Tao Z; Wang B; Xie Y; Wang Y; Li B; Cao J; Qiao X; Zhong S; Hu X Front Immunol; 2022; 13():1056932. PubMed ID: 36479114 [TBL] [Abstract][Full Text] [Related]
10. Immunogenic cell death-related gene landscape predicts the overall survival and immune infiltration status of ovarian cancer. Zhang W; Liu T; Jiang L; Chen J; Li Q; Wang J Front Genet; 2022; 13():1001239. PubMed ID: 36425071 [No Abstract] [Full Text] [Related]
11. Identification and validation of a seven m6A-related lncRNAs signature predicting prognosis of ovarian cancer. Song Y; Qu H BMC Cancer; 2022 Jun; 22(1):633. PubMed ID: 35676619 [TBL] [Abstract][Full Text] [Related]
12. Multi-omics analysis of tumor mutational burden combined with prognostic assessment in epithelial ovarian cancer based on TCGA database. Liu J; Xu W; Li S; Sun R; Cheng W Int J Med Sci; 2020; 17(18):3200-3213. PubMed ID: 33173439 [No Abstract] [Full Text] [Related]
13. Construction and validation of a bladder cancer risk model based on autophagy-related genes. Shen C; Yan Y; Yang S; Wang Z; Wu Z; Li Z; Zhang Z; Lin Y; Li P; Hu H Funct Integr Genomics; 2023 Jan; 23(1):46. PubMed ID: 36689018 [TBL] [Abstract][Full Text] [Related]
14. Identification and validation of pyroptosis-related gene landscape in prognosis and immunotherapy of ovarian cancer. Gao L; Ying F; Cai J; Peng M; Xiao M; Sun S; Zeng Y; Xiong Z; Cai L; Gao R; Wang Z J Ovarian Res; 2023 Jan; 16(1):27. PubMed ID: 36707884 [TBL] [Abstract][Full Text] [Related]
15. Identifying the Role of Oxidative Stress-Related Genes as Prognostic Biomarkers and Predicting the Response of Immunotherapy and Chemotherapy in Ovarian Cancer. Liu Q; Yang X; Yin Y; Zhang H; Yin F; Guo P; Zhang X; Sun C; Li S; Han Y; Yang Z Oxid Med Cell Longev; 2022; 2022():6575534. PubMed ID: 36561981 [TBL] [Abstract][Full Text] [Related]
16. Identification of seven hypoxia-related genes signature and risk score models for predicting prognosis for ovarian cancer. Huang Y; Zhou Y; Zhang M Funct Integr Genomics; 2023 Jan; 23(1):39. PubMed ID: 36642729 [TBL] [Abstract][Full Text] [Related]
17. Multi-omics analysis revealing a senescence-relevant lncRNAs signature for the assessment of response to immunotherapy for breast cancer. Yu Z; Zhu Y; Ji J Medicine (Baltimore); 2023 Jul; 102(28):e34287. PubMed ID: 37443486 [TBL] [Abstract][Full Text] [Related]
18. Establishment of an ovarian cancer omentum metastasis-related prognostic model by integrated analysis of scRNA-seq and bulk RNA-seq. Zhang D; Lu W; Cui S; Mei H; Wu X; Zhuo Z J Ovarian Res; 2022 Nov; 15(1):123. PubMed ID: 36424614 [TBL] [Abstract][Full Text] [Related]
19. The signature of cuproptosis-related immune genes predicts the tumor microenvironment and prognosis of prostate adenocarcinoma. Yao K; Zhang R; Li L; Liu M; Feng S; Yan H; Zhang Z; Xie D Front Immunol; 2023; 14():1181370. PubMed ID: 37600770 [TBL] [Abstract][Full Text] [Related]
20. Cuproptosis-Related Signature Predicts the Prognosis, Tumor Microenvironment, and Drug Sensitivity of Hepatocellular Carcinoma. Qi X; Guo J; Chen G; Fang C; Hu L; Li J; Zhang C J Immunol Res; 2022; 2022():3393027. PubMed ID: 36438201 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]